Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
343221por Chan, Xin Hui S, Win, Yan Naung, Mawer, Laura J, Tan, Jireh Y, Brugada, Josep, White, Nicholas J“…Eligible studies were prospective, randomised, controlled trials or cohort studies in which individuals received at least one 3-day treatment course of dihydroartemisinin–piperaquine for mass drug administration, preventive therapy, or case management of uncomplicated malaria, with follow-up over at least 3 days. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343222“…METHODS: Seven electronic databases were searched to identify randomized controlled trials (RCTs) that compared the differences between different therapy regimens based on TwHF for patients with PNS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343223por Tan, Charles Y., Immermann, Fred W., Sebastian, Shite, Pride, Michael W., Pavliakova, Danka, Belanger, Kelly A., Watson, Wendy, Scott, Daniel A., Sidhu, Mohinder, Jansen, Kathrin U., Giardina, Peter C.“…Serum samples were selected from four pivotal 13-valent pneumococcal conjugate vaccine (13vPnC; Prevnar 13) clinical trials on the basis of their serotype-specific IgG concentrations by ELISA. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343224por Münch, Stefan, Pigorsch, Steffi U., Devečka, Michal, Dapper, Hendrik, Weichert, Wilko, Friess, Helmut, Braren, Rickmer, Combs, Stephanie E., Habermehl, Daniel“…The putative equivalence of dCRT with Carb/TAX in this setting should be further investigated in prospective trials. However, our data reveal that the risk of significant myelotoxicity increases with patient age and therefore other chemotherapy regimens might be evaluated in elderly patients.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343225por Huang, Yinqiu, Huang, Xiaojie, Luo, Yadong, Zhou, Yihong, Tao, Xingbao, Chen, Hui, Song, Aixin, Chen, Yaokai, Wu, Hao“…Methods: In this meta-analysis, we searched randomized controlled trials and observational cohort studies to evaluate outcomes of second-line ART for patients with HIV who failed first-line therapy. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343226por Wang, Min, Kong, Weimin, He, Biyu, Li, Zhongqi, Song, Huan, Shi, Peiyi, Wang, Jianming“…However, intervention trials have produced inconsistent results. We hypothesized that genetic and epigenetic changes in the key genes of the vitamin D metabolic pathway may partly explain the differences between studies. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343227por El Shafie, Rami A, Weber, Dorothea, Bougatf, Nina, Sprave, Tanja, Oetzel, Dieter, Huber, Peter E, Debus, Jürgen, Nicolay, Nils H“…CONCLUSIONS: The acceptance of mobile apps for the surveillance and follow-up of cancer patients undergoing radiotherapy is high; this high acceptance level will serve as a basis for future clinical trials investigating the clinical benefits of mobile app–based treatment support. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343228por Burgess, Gary, Boyce, Malcolm, Jones, Margaret, Larsson, Lars, Main, Mark J., Morgan, Frazer, Phillips, Peter, Scrimgeour, Alison, Strimenopoulou, Foteini, Vajjah, Pavan, Zamacona, Miren, Palframan, Roger“…This study is listed on ClinicalTrials.gov (NCT02473939). FINDINGS: In the VR942 and placebo groups, treatment-emergent adverse events (TEAEs) were reported in 10/30 (33%) and 0/10 (0%) healthy participants, and in 16/29 (55%) and 9/16 (56%) participants with asthma, respectively. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343229por Lindenblatt, Dennis, Terraneo, Nastassja, Pellegrini, Giovanni, Cohrs, Susan, Spycher, Philipp René, Vukovic, David, Béhé, Martin, Schibli, Roger, Grünberg, Jürgen“…Five PKIs (alisertib, MK1775, MK2206, saracatinib, temsirolimus) were chosen for cytotoxicity screenings based on their current clinical trials in the treatment of ovarian cancer and their influence on cell cycle regulation and DNA damage repair pathways. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343230por Chen, Datian, Zhang, Xiang, Gao, Guangyi, Shen, Lili, Xie, Jiaqi, Qian, Xiaoping, Wang, Huiyu“…The inclusion criteria were RCT (randomized controlled trials) studies that evaluated the efficacy of anti-EGFR mAbs based on primary tumor location. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343231por Rowe, Alexander K, Rowe, Samantha Y, Peters, David H, Holloway, Kathleen A, Chalker, John, Ross-Degnan, Dennis“…Eligible study designs were controlled trials and interrupted time series. We only included strategy-versus-control group comparisons. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343232por Breault, Lorraine J., Rittenbach, Katherine, Hartle, Kelly, Babins-Wagner, Robbie, de Beaudrap, Catherine, Jasaui, Yamile, Ardell, Emily, Purdon, Scot E., Michael, Ashton, Sullivan, Ginger, Unger, Aakai’naimsskai’piiaakii Sharon Ryder, Vandall-Walker, Lorin, Necyk, Brad, Krawec, Kiara, Manafò, Elizabeth, Mason-Lai, Ping“…To help support patient-oriented depression research priority setting in Alberta, the Patient Engagement (PE) Platform of the Alberta Strategy for Patient Oriented Research Support for People and Patient-Oriented Research and Trials (SUPPORT) Unit designed, along with the support of their partners in addictions and mental health, an explit process to engage patients in the design and execution of the DRPS. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343233por Lotta, Luca A., Stewart, Isobel D., Sharp, Stephen J., Day, Felix R., Burgess, Stephen, Luan, Jian’an, Bowker, Nicholas, Cai, Lina, Li, Chen, Wittemans, Laura B. L., Kerrison, Nicola D., Khaw, Kay-Tee, McCarthy, Mark I., O’Rahilly, Stephen, Scott, Robert A., Savage, David B., Perry, John R. B., Langenberg, Claudia, Wareham, Nicholas J.“…Studying whether these agents will reduce cardiovascular events or diabetes risk when added to existing lipid-lowering drugs would require large outcome trials. Human genetics studies can help prioritize or deprioritize these resource-demanding endeavors. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343234por Castel, David, Philippe, Cathy, Kergrohen, Thomas, Sill, Martin, Merlevede, Jane, Barret, Emilie, Puget, Stéphanie, Sainte-Rose, Christian, Kramm, Christof M., Jones, Chris, Varlet, Pascale, Pfister, Stefan M., Grill, Jacques, Jones, David T. W., Debily, Marie-Anne“…As these characteristics drive different phenotypes, these findings may have important implication for the design of future trials in these specific types of neoplasms. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-018-0614-1) contains supplementary material, which is available to authorized users.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343235“…This study aims to determine the causes and risk factors of death in a single center European League Against Rheumatism Scleroderma Trials and Research Group (EUSTAR) cohort at the Peking Union Medical College Hospital (PUMCH) in China. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343236por Choo, Vivian L, Viguiliouk, Effie, Blanco Mejia, Sonia, Cozma, Adrian I, Khan, Tauseef A, Ha, Vanessa, Wolever, Thomas M S, Leiter, Lawrence A, Vuksan, Vladimir, Kendall, Cyril W C, de Souza, Russell J, Jenkins, David J A, Sievenpiper, John L“…However, certainty in these estimates is low, and more high quality randomised controlled trials are needed. STUDY REGISTRATION: Clinicaltrials.gov (NCT02716870).…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343237por Aslam, Saima, Gilbey, Timothy, Maddocks, Susan, Morales, Sandra, Lehman, Susan, Branston, Steven, Fabijan, Aleksandra Petrovic, Furr, Carrie-Lynn Langlais, Rosas, Francisco, Bilinsky, Igor, Grint, Paul, Schooley, Robert T, Iredell, Jonathan“…BT appears to be a safe adjunct to antibiotic therapy in life-threatening S. aureus and P. aeruginosa infections and is a promising candidate for controlled clinical trials. DISCLOSURES: S. Morales, AmpliPhi Biosciences: Employee, Salary. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343238por Mendes, Rodrigo E, Castanheira, Mariana, Armstrong, Eliana S, Steenbergen, Judith N, Flamm, Robert K“…BACKGROUND: Omadacycline is a novel aminomethylcycline that recently completed Phase 3 clinical trials for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and community-acquired bacterial pneumonia (CABP). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343239“…Simulations were performed by bootstrapping from a database of >1,400 infected patients enrolled in clinical trials to achieve n = 1,000 per renal function group defined by varying creatinine clearance ranges. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343240por Tie, Yunfeng, McPhail, Brooks, Hong, Huixiao, Pearce, Bruce A., Schnackenberg, Laura K., Ge, Weigong, Buzatu, Dan A., Wilkes, Jon G., Fuscoe, James C., Tong, Weida, Fowler, Bruce A., Beger, Richard D., Demchuk, Eugene“…The categorization was carried out using information from clinical trials because currently available in vitro high-throughput screening data were not fully representative of the in vivo potency of inhibition. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto